XBKK
CMR
Market cap187mUSD
Nov 12, Last price
1.43THB
Name
Chiang Mai Ram Medical Business PCL
Chart & Performance
P/E
44.61
P/S
1.10
EPS
0.03
Div Yield, %
3.85%
Shrs. gr., 5y
0.24%
Rev. gr., 5y
6.13%
Revenues
5.29b
+4.39%
Net income
131m
-40.07%
CFO
922m
-5.15%
Dividend
Dec 29, 20250.1043 THB/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Chiang Mai Ram Medical Business Public Company Limited, together with its subsidiaries, operates a medical care center in Thailand. It offers medical services in the areas of internal medicine, cardiology, general practice, pediatric, orthopedic and general surgery, pediatric surgery, obstetrics-gynecology, radiology, dentistry, anesthetic, ENT, and eye; and operates sub-specialty clinics for urology, neurology, endocrinology, oncology, hematology, plastic surgery, GI tract, and dermatology, as well as infertile and gynecologic oncology clinics. The company also provides dental, X-ray, CT colonoscopy, cardiac catheterization, gynecologic cancer, back pain, physical therapy and rehabilitation, operating theatre, laboratory examination, real-time PCR, ambulance, and CRD and health check-up services; and insurance products. It operates a medical care center under the Lanna Hospital name. The company was founded in 1974 and is headquartered in Chiang Mai, Thailand. Chiang Mai Ram Medical Business Public Company Limited is a subsidiary of Vibhavadi Medical Center Public Company Limited.
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||